GEIS Group GEIS Group

ACCESS YOUR ACCOUNT

User
Password
Remember me
  • Forgot your password?
  • Forgot User?
  • Español
  • English

Main Menu

  • About us
    • History of GEIS
    • Mission, vision and values
    • Organizational Structure
    • Our Collaborators
    • Reference Centers, Units and Services (CSUR)
  • What are sarcomas?
    • Soft tissue sarcomas
    • Skeletal sarcomas
    • Ewing sarcomas
    • Gastrointestinal Stromal Tumor (GIST)
    • Pediatric sarcoma
    • Treatments
      • Surgery
      • Chemotherapy
      • Radiotherapy
  • Patients
    • How can we help you
    • Patient associations
    • Where to find more information
    • Movements for patients
      • Ivan Rock
      • Un Narciso para Soledad
  • Scientific Activity
    • Clinical Trials
      • What are clinical trials?
      • Open trials
      • Closed trials
      • Other non-GEIS trials
    • Scientific Journals
      • Papers to international congresses
      • National/international articles
      • Other publications of interest
      • Book chapters / monographs
    • Guides and nomograms
      • GEIS guidelines
      • European and American guides
      • Nomograms
    • Education
      • Advanced Course on Sarcoma
      • Masters Degree on sarcoma
      • GEIS scientific endorsement
      • GEIS presentations
      • Other courses/ Masters
    • Scholarships and Awards
      • José María Buesa scholarships
      • Mari Paz Jiménez Casado Foundation scholarships
      • Other Scholarships
      • Buesa Awards
      • VyDA-GEIS Scholarship
      • APSATUR Scholarships
    • Links
      • Professional Associations
      • Other related institutions
  • GEIS Symposiums
    • 2023 Symposium
    • 2022 Symposium
    • 2021 Symposium
    • 2020 Symposium
    • 2019 Symposium
    • 2018 Symposium
    • 2017 Symposium
    • 2016 Symposium
    • Previous Symposiums
  • Events
  • News
    • GEIS News
    • ESMO News
    • Hindawi Publishing Corporation – Sarcoma
    • Clinical Sarcoma Research
    • Sarcoma News
    • Healthcare Industry Today
  • Donate
  • Partners
    • Join us
    • GEIS members
    • Work groups
    • GEIS Young Researchers Groups
    • Regulations
    • Proceedings
    • Newsletters
    • Download GEIS Report and accounts
    • Access to the National Registry
    • Reports
  • About us
    • History of GEIS
    • Mission, vision and values
    • Organizational Structure
    • Our Collaborators
    • Reference Centers, Units and Services (CSUR)
  • What are sarcomas?
    • Soft tissue sarcomas
    • Skeletal sarcomas
    • Ewing sarcomas
    • Gastrointestinal Stromal Tumor (GIST)
    • Pediatric sarcoma
    • Treatments
      • Surgery
      • Chemotherapy
      • Radiotherapy
  • Patients
    • How can we help you
    • Patient associations
    • Where to find more information
    • Movements for patients
      • Ivan Rock
      • Un Narciso para Soledad
  • Scientific Activity
    • Clinical Trials
      • What are clinical trials?
      • Open trials
      • Closed trials
      • Other non-GEIS trials
    • Scientific Journals
      • Papers to international congresses
      • National/international articles
      • Other publications of interest
      • Book chapters / monographs
    • Guides and nomograms
      • GEIS guidelines
      • European and American guides
      • Nomograms
    • Education
      • Advanced Course on Sarcoma
      • Masters Degree on sarcoma
      • GEIS scientific endorsement
      • GEIS presentations
      • Other courses/ Masters
    • Scholarships and Awards
      • José María Buesa scholarships
      • Mari Paz Jiménez Casado Foundation scholarships
      • Other Scholarships
      • Buesa Awards
      • VyDA-GEIS Scholarship
      • APSATUR Scholarships
    • Links
      • Professional Associations
      • Other related institutions
  • GEIS Symposiums
    • 2023 Symposium
    • 2022 Symposium
    • 2021 Symposium
    • 2020 Symposium
    • 2019 Symposium
    • 2018 Symposium
    • 2017 Symposium
    • 2016 Symposium
    • Previous Symposiums
  • Events
  • News
    • GEIS News
    • ESMO News
    • Hindawi Publishing Corporation – Sarcoma
    • Clinical Sarcoma Research
    • Sarcoma News
    • Healthcare Industry Today
  • Donate
  • Partners
    • Join us
    • GEIS members
    • Work groups
    • GEIS Young Researchers Groups
    • Regulations
    • Proceedings
    • Newsletters
    • Download GEIS Report and accounts
    • Access to the National Registry
    • Reports
  1. Home
  2. News
  3. ESMO News

ESMO: European Society for Medical Oncology

The latest news from ESMO
  1. EMA Recommends Granting a Marketing Authorisation for Piflufolastat (18F)

    The benefit of this diagnostic radiopharmaceutical is its potential to diagnose prostate cancer during primary staging of patients at high risk and in the staging of patients with a suspected recurrence

  2. Olaparib Plus Bevacizumab Provides Clinically Meaningful OS Improvement for Newly Diagnosed Patients with Homologous Recombination Deficiency-Positive Advanced Ovarian Cancer

    Findings from the prespecified final overall survival analysis of the PAOLA-1/ENGOT-ov25 study

  3. FDA Grants Accelerated Approval to Epcoritamab-bysp for Relapsed or Refractory Diffuse Large B-Cell Lymphoma and High-Grade B-Cell Lymphoma

    Evidence for efficacy is based on the results from the EPCORE NHL-1 study

  4. Significant PFS Benefit in Patients with HR-positive, HER2-negative MBC Who Switched Endocrine Treatment and Received Ribociclib After Previous CDK4/6 Inhibitor and Different Endocrine Therapy

    Findings from the MAINTAIN study

  5. Use of Immune Checkpoint Inhibitors is Safe and Effective in Patients with Cancer and HIV Even in Those on Antiretroviral Therapy

    Findings from the CATCH-IT Consortium study

Grupo GEIS

ABOUT GEIS

  • About us
  • What are sarcomas
  • Patients
  • Request GEIS scientific endorsement

INFORMATION

  • GEIS Symposiums
  • Schedule
  • News
  • Employment opportunities
 

This site contents are not a valid substitute for medical diagnosis, prognosis or treatment given by a doctor. GEIS must insist that the decisions related to sarcoma patients must always be sanctioned by a specialist familiar to this condition after personally meeting the subject. This website operates under its User Terms and Conditions.

Copyright © 2023 GEIS Group. All Rights Reserved. Diseño Comuniland.
  • Legal disclaimer
  • Privacy policy
  • Sitemap
  • Cookies
  • Contact us